Author

Xingbo Cheng

Observed name: Cheng, Xingbo

Institutions: Henan University, Zhengzhou University, Henan Provincial People's Hospital

Observed institutions: Harbin Medical University, Henan University, Zhengzhou University, Soochow University, Henan Provincial People's Hospital, First Affiliated Hospital of Soochow University, First Affiliated Hospital of Harbin Medical University

ORCID: 0000-0003-2073-1583

Observed ORCID: 0000-0003-2073-1583

OpenAlex ID: A5101779581

Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway

2019 · Yuanyuan Liu, Mengjie Wang, et al. · Life Sciences · 39

Glucose fluctuation increased mesangial cell apoptosis related to AKT signal pathway

2019 · Changjiang Ying, Shanshan Wang, et al. · Archives of Medical Science · 31

Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma

2021 · Li Hu, Zhibin Han, et al. · Frontiers in Genetics · 20

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients

2021 · Zhendong Liu, Wang Zhang, et al. · Molecular Medicine · 19

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma

2022 · Runze Liu, Zhendong Liu, et al. · Frontiers in Oncology · 12

A novel SGLT2 inhibitor, SU-011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain

2019 · Fei Huang, Fuwei Dai, et al. · Journal of Pharmacy and Pharmacology · 3

BARD1 phase separation orchestrates a repair hub by enriching XRCC5 to drive chemoresistance in glioma

2026 · Chao Wang, Xingbo Cheng, et al. · Life Sciences

HAT1 regulates the immune microenvironment and promotes the malignant pathology of lower-grade gliomas

2023 · Qingnan Wang, Zhendong Liu, et al. · Research Square

Works count: 9

Citation count: 124

H-index: 5

I10-index: 5